Instruct: Given a question, retrieve relevant documents that answer the question.
Query: Who discovered the HIV virus?
The 2008 Nobel Prize in Physiology or Medicine was awarded to Montagnier and Françoise Barré-Sinoussi for the discovery of HIV. They shared the Prize with Harald zur Hausen, who discovered that human papilloma viruses can cause cervical cancer. Montagnier said he was "surprised" that Robert Gallo was not also recognized by the Nobel Committee: "It was important to prove that HIV was the cause of AIDS, and Gallo had a very important role in that. I'm very sorry for Robert Gallo." According to Maria Masucci, a member of the Nobel Assembly, "there was no doubt as to who made the fundamental discoveries."
Albert Ludwig Sigesmund Neisser (22 January 1855, Schweidnitz – 30 July 1916, Breslau) was a German physician who discovered the causative agent (pathogen) of gonorrhea, a strain of bacteria that was named in his honour ("Neisseria gonorrhoeae").
Blood types were first discovered by an Austrian Physician Karl Landsteiner working at the Pathological-Anatomical Institute of the University of Vienna (now Medical University of Vienna). In 1900, he found that blood sera from different persons would clump together (agglutinate) when mixed in test tubes, and not only that some human blood also agglutinated with animal blood. He wrote a two-sentence footnote:
The Human Genome Project (HGP) was an international scientific research project with the goal of determining the sequence of nucleotide base pairs that make up human DNA, and of identifying and mapping all of the genes of the human genome from both a physical and a functional standpoint. It remains the world's largest collaborative biological project. After the idea was picked up in 1984 by the US government when the planning started, the project formally launched in 1990 and was declared complete on April 14, 2003. Funding came from the US government through the National Institutes of Health (NIH) as well as numerous other groups from around the world. A parallel project was conducted outside government by the Celera Corporation, or Celera Genomics, which was formally launched in 1998. Most of the government-sponsored sequencing was performed in twenty universities and research centers in the United States, the United Kingdom, Japan, France, Germany and China.
Many vaccines for infectious diseases are produced in fertile chicken eggs. The basis of this technology was the discovery in 1931 by Alice Miles Woodruff and Ernest William Goodpasture at Vanderbilt University that the rickettsia and viruses that cause a variety of diseases will grow in chicken embryos. This enabled the development of vaccines against influenza, chicken pox, smallpox, yellow fever, typhus, Rocky mountain spotted fever and other diseases.
Polyvinyl chloride (PVC) was discovered by French physicist Henri Victor Regnault, and German physicist Eugen Baumann. Klatte designed the production process, although never successfully commercialised it. Klatte is sometimes incorrectly attributed to be the discoverer or inventor of PVC.
In 1880, while working in the military hospital in Constantine, Charles Louis Alphonse Laveran discovered that the cause of malaria is a protozoan. He observed the parasites in a blood smear taken from a soldier who had just died of malaria. For this, he received the 1907 Nobel Prize for Physiology or Medicine. This was the first time that protozoa were shown to be a cause of disease. His work helped inspire researchers and veterinarians today to try to find a cure for malaria in animals.
The true identity of the discoverers of carbon nanotubes is a subject of some controversy. A 2006 editorial written by Marc Monthioux and Vladimir Kuznetsov in the journal "Carbon" described the interesting and often-misstated origin of the carbon nanotube. A large percentage of academic and popular literature attributes the discovery of hollow, nanometer-size tubes composed of graphitic carbon to Sumio Iijima of NEC in 1991. He published a paper describing his discovery which initiated a flurry of excitement and could be credited by inspiring the many scientists now studying applications of carbon nanotubes. Though Iijima has been given much of the credit for discovering carbon nanotubes, it turns out that the timeline of carbon nanotubes goes back much further than 1991.
An important discovery was made by Patrick Manson in 1877 that mosquito could transmit human filarial parasite. Inferring from such novel discovery Albert Freeman Africanus King proposed the hypothesis that mosquitoes were the source of malaria. In the early 1890s Manson himself began to formulate the complete hypothesis, which he eventually called the mosquito-malaria theory. According to Manson malaria was transmitted from human to human by a mosquito. The theory was scientifically proved by Manson's confidant Ronald Ross in the late 1890s. Ross discovered that malaria was transmitted by the biting of specific species of mosquito. For this Ross won the Nobel Prize for Physiology or Medicine in 1902. Further experimental proof was provided by Manson who induced malaria in healthy human subjects from malaria-carrying mosquitoes. Thus the theory became the foundation of malariology and the strategy of control of malaria.
A German physician, Johann Friedrich Meckel, must have been the first to see "P. falciparum" but not knowing what it was. In 1847 he reported the presence of black pigment granules from the blood and spleen of a patient who died of malaria. The French Army physician Charles Louis Alphonse Laveran, while working at Bône Hospital (now Annaba in Algeria), correctly identified the parasite as a causative pathogen of malaria in 1880. He presented his discovery before the French Academy of Medicine in Paris, and published it in "The Lancet", in 1881. He gave the scientific name "Oscillaria malariae". But his discovery was received with skepticism mainly because by that time leading physicians such as Theodor Albrecht Edwin Klebs and Corrado Tommasi-Crudeli claimed that they had discovered a bacterium (which they called "Bacillus malariae") as the pathogen of malaria. Laveran's discovery was widely accepted only after five years when Camillo Golgi confirmed the parasite using better microscope and staining technique. Laveran was awarded the Nobel Prize in Physiology or Medicine in 1907 for his work. In 1900, the Italian zoologist Giovanni Battista Grassi categorized "Plasmodium" species based on the timing of fever in the patient; malignant tertian malaria was caused by "Laverania malariae" (now "P. falciparum"), benign tertian malaria by "Haemamoeba vivax" (now "P. vivax"), and quartan malaria by "Haemamoeba malariae" (now "P. malariae").
Alexander Fleming had first discovered penicillin by accident in 1928, but at that time believed it had little application. When Florey and his team recognised the potential of the discovery for combating bacterial infection, they faced the problem of how to manufacture penicillin in sufficient quantities to be of use. Heatley, although the junior member of the team, possessed a natural gift for ingenuity and invention. It was he who suggested transferring the active ingredient of penicillin back into water by changing its acidity, thus purifying the penicillin.
Human herpesvirus 7 (HHV-7) is one of nine known members of the Herpesviridae family that infects humans. HHV-7 is a member of Betaherpesviridae, a subfamily of the Herpesviridae that also includes HHV-6 and "cytomegalovirus" (HHV-5 or HCMV). HHV-7 often acts together with HHV-6, and the viruses together are sometimes referred to by their genus, "Roseolovirus". HHV-7 was first isolated in 1990 from CD4+ T cells taken from peripheral blood lymphocytes.
For decades biologists had been at work on the medicine that became penicillin. In 1928, Scottish biologist Alexander Fleming discovered a substance that killed a number of disease-causing bacteria. In 1929, he named the new substance "penicillin". His publications were largely ignored at first, but it became a significant antibiotic in the 1930s. In 1930, Cecil George Paine, a pathologist at Sheffield Royal Infirmary, used penicillin to treat sycosis barbae, eruptions in beard follicles, but was unsuccessful. Moving on to ophthalmia neonatorum, a gonococcal infection in infants, he achieved the first recorded cure with penicillin, on November 25, 1930. He then cured four additional patients (one adult and three infants) of eye infections, but failed to cure a fifth.
Mitochondrial DNA was discovered in the 1960s by Margit M. K. Nass and Sylvan Nass by electron microscopy as DNase-sensitive threads inside mitochondria, and by Ellen Haslbrunner, Hans Tuppy and Gottfried Schatz by biochemical assays on highly purified mitochondrial fractions.
A report produced in November 2015 by the Human Dignity Trust in association with the Commonwealth Lawyers' Association claims that countries that continue to criminalize same-sex relationships were worsening the impacts of the HIV/AIDS crisis. The report estimates that some 2.9 billion people live in Commonwealth countries where consensual homosexuality is punishable, and approximately 174 million living there may identify as LGBT. It found that: ""There is a direct link between criminalizing laws and increased rates of HIV, and the Commonwealth undeniably demonstrates this link. The Commonwealth accounts for approximately 30% of the world's population but over 60% of HIV cases worldwide. This situation has gotten progressively worse.""
The discovery of carbon nanotubes is largely attributed to Sumio Iijima of NEC in 1991, although carbon nanotubes have been produced and observed under a variety of conditions prior to 1991. Iijima's discovery of multi-walled carbon nanotubes in the insoluble material of arc-burned graphite rods in 1991 and Mintmire, Dunlap, and White's independent prediction that if single-walled carbon nanotubes could be made, then they would exhibit remarkable conducting properties helped create the initial buzz that is now associated with carbon nanotubes. Nanotube research accelerated greatly following the independent discoveries by Bethune at IBM and Iijima at NEC of "single-walled" carbon nanotubes and methods to specifically produce them by adding transition-metal catalysts to the carbon in an arc discharge.
In August 1961, at the International Congress of Biochemistry in Moscow, Nirenberg presented his paper. The experimentation with synthetic RNA in a cell-free system was a key technical innovation. In 1961, when they announced their methods for decoding the relationship of mRNA to amino acids, there was still a lot of experimentation required before the entire code was deciphered. The scientists had to determine which bases made up each codon, then determine the sequence of bases in the codons. This proved to be a tremendous amount of work.
Graphene was discovered at the University of Manchester in 2004 under Prof Sir Andre Geim and Sir Konstantin Novoselov.
At the Calico Printers' Association in Manchester in 1941, John Rex Whinfield and James Tennant Dickson discovered polyethylene terephthalate, known as PET, a common polyester compound found in plastic bottles and food, and also known as Terylene or Dacron. Cheslene and Crepes of Macclesfield discovered crimplene (the fabric that is now referred to as polyester). ICI Dyestuffs at Hexagon House, in Blackley in north Manchester, discovered Procion dyes. At the Winnington Laboratory on 27 March 1933, Eric Fawcett and Reginald Gibson discovered polythene in an ICI laboratory in Northwich, when reacting benzaldehyde with ethene at a pressure of 2,000 atmospheres; the process was improved in 1935 by Sir Michael Perrin.
In 1958, Beecham scientists in the UK discovered the penicillin nucleus, 6-APA. From that starting material, a large number of new semisynthetic penicillins could be designed, whose activity was directed against problem infections.
Herpes simplex research includes all medical research that attempts to prevent, treat, or cure herpes, as well as fundamental research about the nature of herpes. Examples of particular herpes research include drug development, vaccines and genome editing. HSV-1 and HSV-2 are commonly thought of as oral and genital herpes respectively, but other members in the herpes family include chickenpox (varicella/zoster), cytomegalovirus (CMV), and Epstein-Barr (EBV).
The ABO blood group system was discovered in the year 1900 by Karl Landsteiner. Jan Janský is credited with the first classification of blood into the four types (A, B, AB, and O) in 1907, which remains in use today. In 1907 the first blood transfusion was performed that used the ABO system to predict compatibility. The first non-direct transfusion was performed on March 27, 1914. The Rhesus factor was discovered in 1937.
In June 1984, Burroughs-Wellcome virologist Marty St. Clair set up a program to discover drugs with the potential to inhibit HIV replication. Burroughs-Wellcome had expertise in nucleoside analogs and viral diseases, led by researchers including George Hitchings, Gertrude Elion, David Barry, Paul (Chip) McGuirt Jr., Philip Furman, Martha St. Clair, Janet Rideout, Sandra Lehrman and others. Their research efforts were focused in part on the viral enzyme reverse transcriptase. Reverse transcriptase is an enzyme that retroviruses, including HIV, utilize to replicate themselves. Secondary testing was performed in mouse cells infected with the retroviruses Friend virus or Harvey sarcoma virus, as the Wellcome group did not have a viable in-house HIV antiviral assay in place at that time, and these other retroviruses were believed to represent reasonable surrogates. AZT proved to be a remarkably potent inhibitor of both Friend virus and Harvey sarcoma virus, and a search of the company's records showed that it had demonstrated low toxicity when tested for its antibacterial activity in rats many years earlier. Based in part on these results, AZT was selected by nucleoside chemist Janet Rideout as one of 11 compounds to send to the NCI for testing in that organization's HIV antiviral assay.
Haseltine's approach to the epidemic was threefold:The first goal was achieved by understanding the structure and function of the virus. Haseltine's laboratory, working in collaboration with two other groups, determined the complete sequence of the viral genome and discovered the genes that specify the virus capsid, polymerase, protease, ribonuclease H, integrase and envelop genes. The first application of this knowledge was to design a fragment of the virus envelope protein that could be used to accurately detect antibodies to HIV in those infected, forming the basis of an accurate diagnostic test. This protein fragment was used by Cambridge BioSciences (Later named Cambridge BioTech) to develop a rapid test for HIV infection that could be used at home. It was only in 2012 that the US FDA approved a similar home HIV test kit.
Haseltine and his laboratory quickly showed that damage to any of the viral genes that specify the virus capsid, polymerase, protease, ribonuclease, integrase and envelope genes killed the virus and therefore that proteins specified by each gene were good targets for anti-viral drugs. Over the next several years his laboratory isolated each of the genes and their proteins in pure form and developed methods that were used by the pharmaceutical companies to discover new anti viral drugs. The first HIV specific protease inhibitor Nelfinavir, was developed as a part of a three way collaboration between the Haseltine laboratory, Cambridge BioSciences, a company Haseltine and his colleagues created, and Agouron Pharmaceuticals. The combination of an HIV polymerase inhibitor such as AZT and an anti protease drug lead to the first long term survival of those infected with HIV. Haseltine proposed the use of combination chemotherapy, targeting multiple drugs against different viral proteins as the basis for effective therapy. Today those ideas have proven out; the pharmaceutical industry has developed more than forty drugs that inhibit the HIV polymerase, protease, integrase, and envelope proteins. Combinations of these drugs have transformed HIV infection from a near universally fatal disease to one that with proper management usually can be successfully treated for decades.
In early 2000, researchers discovered a small group of sex workers in Nairobi, Kenya who were estimated to have sexual contact with 60 to 70 HIV positive clients a year without signs of infection. These sex workers were not found to have the delta mutation leading scientists to believe other factors could create a genetic resistance to HIV. Researchers from Public Health Agency of Canada have identified 15 proteins unique to those virus-free sex workers. Later, however some sex workers were discovered to have contracted the virus, leading Oxford University researcher Sarah Rowland-Jones to believe continual exposure is a requirement for maintaining immunity.
He began his work as a herpes virologist with a specific focus on developing drug therapeutics for orolabial and genital herpes and severe life-threatening infections like herpes encephalitis. When HIV was identified as a virus in the 1980s, Schinazi and his fellow researchers directed their attention towards the problem. He was able to translate his knowledge gained through his work on the herpes viruses towards addressing HIV and HBV. He is credited for setting up the first-ever HIV laboratory at Emory University complete with a protocol on how to handle the dangerous virus in the laboratory setting so he and his team could pursue the development of novel antiviral drugs. In 1987, he helped Prusoff’s laboratory discover that d4T, a nucleoside analog, had selective activity against HIV.